Xiaolin Zi
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
-
- Silymarin and Mushroom Poisoning
- Prostate Cancer Treatment and Research
- Sarcoma Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 15
- Sarcoma Diagnosis and Treatment 11
- Silymarin and Mushroom Poisoning 6
-
- Wnt/β-catenin signaling in development and cancer 11
- Ubiquitin and proteasome pathways 6
- Co-authors
- Michaël Pollak (6 shared papers)Rajesh Agarwal (5 shared papers)Anne R. Simoneau (11 shared papers)Bang H. Hoang (20 shared papers)Jun Xie (17 shared papers)Desmond D. Mascarenhas (1 shared paper)Yuqing Zhao (1 shared paper)Yi Guo (13 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)European Journal of Medicinal Chemistry (4 papers)Molecular Cancer (3 papers)Biochemical and Biophysical Research Communications (3 papers)Current Cancer Drug Targets (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Xiaolin Zi
88 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 103
- Oncology 960
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 1.6k
- Drug Discovery 7
- Cancer Research 311
Countries citing papers authored by Xiaolin Zi
This map shows the geographic impact of Xiaolin Zi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zi more than expected).
Fields of papers citing papers by Xiaolin Zi
This network shows the impact of papers produced by Xiaolin Zi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zi. The network helps show where Xiaolin Zi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Zi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 742 | |
| 2 | 1999 | 216 | |
| 3 | 2013 | 203 | |
| 4 | 2005 | 175 | |
| 5 | 2005 | 174 | |
| 6 | 2003 | 170 | |
| 7 | A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. | 1998 | 153 |
| 8 | Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. | 1998 | 150 |
| 9 | 2010 | 119 | |
| 10 | 2014 | 118 | |
| 11 | 2010 | 113 | |
| 12 | 2011 | 106 | |
| 13 | Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. | 2000 | 105 |
| 14 | 2007 | 104 | |
| 15 | 1997 | 99 | |
| 16 | 2006 | 92 | |
| 17 | 2009 | 91 | |
| 18 | 2017 | 86 | |
| 19 | 2010 | 84 | |
| 20 | 2013 | 75 |
About Xiaolin Zi
Xiaolin Zi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Pharmacology, Oncology and Organic Chemistry, having authored 88 papers that have together received 5.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), Sarcoma Diagnosis and Treatment (11 papers), Wnt/β-catenin signaling in development and cancer (11 papers), Flavonoids in Medical Research (11 papers), Synthesis and biological activity (10 papers), Silymarin and Mushroom Poisoning (6 papers), Ubiquitin and proteasome pathways (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (960 citations), Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (1.6k citations), Drug Discovery (7 citations) and Cancer Research (311 citations). Xiaolin Zi has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Michaël Pollak, Rajesh Agarwal, Anne R. Simoneau, Bang H. Hoang, Jun Xie, Desmond D. Mascarenhas, Yuqing Zhao, Yi Guo, Xuesen Li and Yuhong Lu. Their work appears in journals such as Molecular Cancer Therapeutics, European Journal of Medicinal Chemistry, Molecular Cancer, Biochemical and Biophysical Research Communications and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.